Ftse Mib
34.400,99
0,00%
DAX
20.242,57
-0,05%
S&P 500
5.872,16
-2,95%
NASDAQ
19.392,69
-3,56%
Bitcoin
101.159,50
1,09%
Pepperstone
Advertisement
Registration Strip Icon for alerts Registrati per avvisi in tempo reale, portafoglio personalizzato e movimenti di mercato.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Clearmind Medicine Inc (CMND) Clearmind Medicine Inc (CMND) Notizie

Clearmind Medicine Inc

CMND
1,20
-0,07 (-5,51%)
19 Dic 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
16/12/202414:37GLOBEClearmind Medicine and Dr Glitter Pty Ltd Sign Term Sheet..
09/12/202423:12EDGAR2Form S-8 - Securities to be offered to employees in employee..
06/12/202423:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
20/11/202422:01EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
10/10/202422:01EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
10/10/202414:07GLOBEClearmind Medicine Announces IRB Approval for FDA..
01/10/202406:15EDGAR2Form EFFECT - Notice of Effectiveness
26/9/202422:01EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
24/9/202422:30EDGAR2Form POS AM - Post-Effective amendments for registration..
16/9/202422:10EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
16/9/202422:06GLOBEClearmind Medicine Announces the Notice of an International..
16/9/202422:01EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
12/9/202422:01EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
12/9/202414:20GLOBEClearmind Medicine and Yissum File International Patent..
06/9/202422:01EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
06/9/202413:55GLOBESciSparc-Clearmind Medicine Collaboration Leads to..
29/8/202422:25GLOBEClearmind Medicine Announces Publication of its Patent..
21/8/202422:11GLOBEClearmind Medicine Granted U.S. Patent Approval for Binge..
16/8/202422:14GLOBEClearmind Medicine and Yissum Expand Collaboration with..
06/8/202414:57GLOBESciSparc’s Collaboration with Clearmind Medicine Continues..
31/7/202413:44GLOBEClearmind Medicine Concludes the Successful Participation in..
19/7/202413:55GLOBEClearmind Medicine Signs an Agreement to Source..
16/7/202415:02GLOBEClearmind Medicine Obtains IND Approval from the FDA to..
16/7/202412:03GLOBEClearmind Medicine Announces Submission of US Patent..
12/7/202414:02GLOBEClearmind Medicine to Present Groundbreaking Research at..
28/6/202413:55GLOBEClearmind Medicine Granted Patent Approval in Hong Kong for..
20/6/202413:57GLOBEClearmind Medicine Secured Exclusive Global Rights to..
13/6/202422:01EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
13/6/202422:01EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
11/6/202413:44GLOBEClearmind Medicine Revolutionizes the $13 Billion..
10/5/202422:01EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
10/5/202414:24GLOBEClearmind Medicine Advances its Proprietary Psychedelic-..
07/5/202422:01EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
07/5/202413:46GLOBEClearmind Medicine Secures Exclusive Global Rights to..
30/4/202422:15GLOBEClearmind Applies to Cease Being a Reporting Issuer in..
17/4/202413:49GLOBEClearmind Medicine Announces Exclusive Licensing Agreement..
10/4/202413:17GLOBEClearmind Medicine Files U.S. Patent Application for..
09/4/202414:07GLOBEClearmind Medicine CEO Issues Letter to Shareholders
19/3/202412:55GLOBEBreakthrough in Wellness: Clearmind Medicine's Psychedelic..
13/3/202413:14GLOBEClearmind Medicine Obtains Clearance for its Psychedelic-..
13/3/202412:30GLOBEClearmind Medicine Received Approval for a Voluntary..
27/2/202413:58GLOBESciSparc-Clearmind Partnership Yields Three New..
23/2/202413:06GLOBEClearmind Medicine Receives Approval to Commence its Phase..
20/2/202413:14GLOBESciSparc and Clearmind Continue to Strengthen International..
05/2/202413:51GLOBEClearmind Medicine Receives Patent Approval for its..
01/2/202414:15GLOBEClearmind Medicine Announces Exclusive, Long-Term Licensing..
16/1/202417:19GLOBEClearmind Medicine Inc. Closes US$2.4 Million Registered..
11/1/202415:28GLOBEClearmind Medicine Inc. Announces Pricing of $2.4 Million..
10/1/202413:18GLOBEClearmind Medicine Completed Type A Meeting with the FDA
04/1/202413:18GLOBESciSparc and Clearmind Medicine Reflect on Successful..
Apertura: 1,27 Min: 1,1401 Max: 1,30
Chiusura: 1,27

La tua Cronologia

NASDAQ
CMND
Clearmind Medicine
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network